Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)

Published:2022-07-12 Issue:1 Volume:1 Page:14-28
ISSN:2771-1757
Container-title:Health Care Science
language:en
Short-container-title:Health Care Science

Author:

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hcs2.1

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial;Frontiers in Pharmacology;2024-05-27

2. A robust web-based tool to predict viral shedding in patients with Omicron SARS-CoV-2 variants;ERJ Open Research;2024-04-19

3. Advances in the application of traditional Chinese medicine during the COVID-19 recovery period: A review;Medicine;2024-04-05

4. Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications;Pharmaceuticals;2024-03-28

5. Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai;Journal of Clinical Immunology;2024-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3